Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission
E. Donnall Thomas(AbbVie (United States)), Paul L. Weiden(Seattle University), Jean E. Sanders(Carolinas Medical Center), Alexander Fefer(University of Washington), C. Dean Buckner(University of Washington), Howard M. Shulman(Fred Hutch Cancer Center), George E. Sale, Reginald A. Clift(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Rainer Storb(University of Washington), Paul E. Neiman(University of Washington), F L Johnson(University of Washington), Jack W. Singer(Seattle University)
Cited by 646
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Antileukemic Effect of Chronic Graft-versus-Host Disease
|New England Journal of Medicine|1981|1.1k